Literature DB >> 9116421

Clinical data in children with meningococcal meningitis in a Spanish hospital.

C Luaces Cubells1, J J García García, J Roca Martínez, C L Latorre Otín.   

Abstract

Neisseria meningitidis is the main cause of bacterial meningitis in Spain. Of the 213 children included in this study with meningococcal meningitis, 7 died. Mortality was linked to a shorter time from the first symptom to diagnosis (mean time for fatal cases was 9.5 h, mean time for survivors was 19 h, p = 0.034), to deteriorated consciousness (DC) (mortality rate (MR) with DC = 6/87, MR without DC = 1/124, p = 0.02) and to shock (MR with shock = 5/7, MR without shock = 2/206, p < 0.0001). Previous treatment reduced the yield from blood culture (36/54 versus 45/137, p < 0.0001). Positivity in both Gram stain (GS) and cerebrospinal fluid (CSF) culture increased with longer duration of symptoms (mean GS+ = 25 h, GS- = 16 h, p = 0.004; CSF+ = 20 h, CSF- = 12 h, p = 0.001), and blood culture (BC) gave more positive results when carried out earlier (mean BC- = 14 h, BC- = 24 h, p < 0.001). Reduced susceptibility to penicillin was seen in 34% of the strains, and rapidly evolving forms were responsible for most of the deaths; reduced susceptibility was more frequent among strains responsible for death or sequelae (9/15 = 60%) as compared with the more harmless strains (69/ 215 = 32%) (p = 0.04). The progressive reduction of susceptibility to penicillin indicates that it should be replaced by a third-generation cephalosporine.

Entities:  

Mesh:

Year:  1997        PMID: 9116421     DOI: 10.1111/j.1651-2227.1997.tb08826.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  9 in total

Review 1.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  Use of ceftriaxone during epidemics in patients with suspected meningococcal meningitis.

Authors:  Allan R Tunkel
Journal:  Curr Infect Dis Rep       Date:  2006-06       Impact factor: 3.725

3.  Epidemiology of invasive meningococcal disease with decreased susceptibility to penicillin in Ontario, Canada, 2000 to 2006.

Authors:  Elizabeth M Brown; David N Fisman; Steven J Drews; Sharon Dolman; Prasad Rawte; Shirley Brown; Frances Jamieson
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

Review 4.  Bacterial meningitis: current controversies in approaches to treatment.

Authors:  A J Williams; S Nadel
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 5.  Bacterial meningitis in children: critical review of current concepts.

Authors:  Ram Yogev; Judith Guzman-Cottrill
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Treatment of Bacterial Meningitis.

Authors:  Allan R. Tunkel; W. Michael Scheld
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

Review 7.  Acute bacterial meningitis in infants and children: epidemiology and management.

Authors:  Shruti Agrawal; Simon Nadel
Journal:  Paediatr Drugs       Date:  2011-12-01       Impact factor: 3.022

8.  Bacterial meningitis: epidemiology, pathogenesis and management update.

Authors:  Yuliya Nudelman; Allan R Tunkel
Journal:  Drugs       Date:  2009       Impact factor: 9.546

9.  [Hemorrhagic skin lesions associated with infections].

Authors:  R Elling; M Hufnagel; P Henneke
Journal:  Monatsschr Kinderheilkd       Date:  2012-06-10       Impact factor: 0.323

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.